A consortium of investors, led by Nordic Capital and Insight Partners, plan to acquire the company in a deal that would value it at $7.3 billion. It’s expected to close later this year or in early 2022.
Led by Kaiser Permanente, the Series D financing round will enable OM1 to expand its data networks into chronic disease areas, including rheumatology and behavioral health, and advance its AI analytics models.
The company will use the funds to develop new solutions and tools that can identify and correct anomalies in providers’ revenue cycle processes and automate repetitive tasks.
Launched by 14 health systems in February, the data analytics company building a repository of de-identified data will use the funds to develop its platform that aims to support clinical decision making and drug development.
Realyze Intelligence, incubated at and funded by UPMC Enterprises, provides a platform that uses EMR data to identify chronic disease patients and help clinicians link them to appropriate treatment options. The platform leverages not only the structured data available in EMRs but also unstructured clinical notes.
Together, the companies will add race, ethnicity and language information as well as social determinants of health factors to a database of millions of Blues plan members. The insights gleaned will be used to design interventions and develop community partnerships to reduce disparities in care.
After a challenging 2020, health systems are looking to deploy strategies for recovery, especially to bolster financial health. One strategy health executives are considering is investing in predictive modeling technology that can help them manage patient demand and outcomes in the coming year.
In an unusual move, 14 major providers — including Trinity Health, CommonSpirit Health and Tenet — have come together to launch a data analytics company. Insights derived from the company’s platform will be available to providers, biopharma companies and scientific researchers working to advance patient care.
As COVID-19 continues to surge in Los Angeles, LANES is enabling free-flowing data insights – medical, behavioral and socioeconomic ─ to close information gaps and improve clinical decision support for better outcomes.
Consumers today want more flexible and convenient access to care, preferably through the self-service experience they are accustomed to in other areas of their lives. To answer this call, providers are turning to online self-scheduling, which allows patients to book an appointment with the provider of their choice any time of day or night via …
The EHR giant is planning to buy Kantar Health, which provides data, analytics and research to the life sciences industry. Through the acquisition, Cerner aims to provide its clients with more access to data analytics and research expertise and engagement with life sciences companies.
BioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to market, but it’s still pushing forward on other fronts, including a partnership with InstaDeep to deploy artificial intelligence and machine learning across its business. The two companies have been working together in this area since 2019, but …
An integrated coaction model, or iCaM, is ideal for addressing complex multi-specialty parameters associated with health inequities and COVID-19.
The resource includes services and access to a data analytics platform that can help providers identify and address social factors affecting the health of the populations they serve.
Data from a real-time location system, covering nearly 4.3 million square feet, offers the ability to see patients and staff who may have come into proximity with an infected person.
“It’s important to provide our patients with the absolute best access channels to quickly and seamlessly connect with the care they need. Experian Health’s solution guides our patients to the right care and digitally connects them with a confirmed appointment.” – Kaci Husted, Vice President, Benefis Health System It’s shouldn’t come as a surprise that …
As we have heard repeatedly over the past few months, there is a need to think of managing this pandemic in the same way we prepare for a marathon rather than a sprint, says Dr Charles Alessi, chief clinical officer, HIMSS.
Pharmaceutical companies have always had access to a steady stream of data to look at what has happened in the past and to try to predict future prescribing trends. Business intelligence (BI) departments have supported this throughout with timely and effective reporting, within an environment that has seen in recent years a bit of an …
Learn about the knowledge graph that’s helping map relationships between patents, publications and genes in the battle against the novel coronavirus from Dr Alexander Jarasch at the Federal Republic’s main diabetes research facility, DZD, in Germany.
COVID-19 has changed the way millions of Americans access care during COVID-19, leading to the widespread adoption of virtual health and other consumer-centric technologies. Without online self-scheduling however, technologies like telehealth may not reach their full potential. Incorporating a self-scheduling solution that reaps long-term success takes a specific strategy, and with the number self-scheduling vendors …